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There is a substantial burden of respiratory disease in infants in the sub-Saharan Africa
region. Many health care providers (HCPs) that initially receive infants with respiratory dis-
tress may not be adequately skilled to differentiate between mild, moderate and severe
respiratory symptoms, which may contribute to poor management and outcome. Therefore,
respiratory severity scores have the potential to contributing to address this gap.
Objectives
to field-test the use of two existing standardized bronchiolitis severity scores (LIBSS and
ReSViNET) in a population of Rwandan infants (1–12 months) presenting with respiratory ill-
nesses to urban, tertiary, pediatric hospitals and to assess the severity of respiratory dis-
tress in these infants and the treatments used.
Methods
A cross-sectional, validation study, was conducted in four tertiary hospitals in Rwanda.
Infants presenting with difficulty in breathing were included. The LIBSS and ReSViNET
scores were independently employed by nurses and residents to assess the severity of dis-
ease in each infant.
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Results
100 infants were recruited with a mean age of seven months. Infants presented with pneumo-
nia (n = 51), bronchiolitis (n = 36) and other infectious respiratory illnesses (n = 13). Thirty-
three infants had severe disease and survival was 94% using nurse applied LIBSS. Regard-
ing inter-rater reliability, the intra-class correlation coefficient (ICC) for LIBSS and ReSViNET
between nurses and residents was 0.985 (95% CI: 0.98–0.99) and 0.980 (0.97–0.99). The
convergent validity (Pearson’s correlation) between LIBSS and ReSViNET for nurses and
residents was R = 0.836 (p<0.001) and R = 0.815 (p<0.001). The area under the Receiver
Operator Curve (aROC) for admission to PICU or HDU was 0.956 (CI: 0.92–0.99, p<0.001)
and 0.880 (CI: 0.80–0.96, p<0.001) for nurse completed LIBSS and ReSViNET respectively.
Conclusion
LIBSS and ReSViNET were designed for infants with bronchiolitis in resource-rich settings.
Both LIBSS and ReSViNET demonstrated good reliability and validity results, in this cohort
of patients presenting to tertiary level hospitals. This early data demonstrate that these two
scores have the potential to be used in conjunction with clinical reasoning to identify infants
at increased risk of clinical deterioration and allow timely admission, treatment escalation
and therefore support resource allocation in Rwanda.
Introduction
Acute respiratory distress is a frequent cause of pediatric emergency department attendance.
Common etiologies include bronchiolitis and pneumonia [1, 2]. The burden of respiratory dis-
ease remains in Low-Income Countries (LICs), where mechanical ventilation facilities are lim-
ited or unavailable [3]. Deaths from pneumonia and bronchiolitis have been linked to low
health coverage, lack of exclusive breastfeeding, malnutrition, incomplete immunization and
lack of access to an appropriate health care service [4, 5]. Many health care providers (HCPs)
that initially receive infants with respiratory distress may not be adequately skilled to differen-
tiate between mild, moderate and severe respiratory symptoms, which may contribute to poor
management and outcome [6]. Untreated or unsupported pediatric respiratory distress can
lead to respiratory failure, identified as the main cause of cardiac arrest in children [7]. Contin-
uous positive airway pressure (CPAP) can help to prevent progression to respiratory failure
[3]. However, identifying those children who need admission and those that need higher levels
of care is dependent upon HCPs with the necessary skills and tools.
Risk prediction models offer the potential to support such clinical decision making, and in
respiratory disease can help to identify children that require admission and respiratory support
[8]. One such model is a clinical measurement instrument consisting of clinical signs and
symptoms that are grouped together to measure an intended construct. The validation of such
an instrument should ideally include: assessment of reliability, responsiveness, and usability
[9–15]. Instruments could be used by HCPs in their decision making, such as when to admit
children, or when to escalate care of infants with respiratory distress. In order to be fit for pur-
pose, such an instrument should be validated, reliable, quick to perform, and straightforward
to interpret in the clinical context [15]. It should not involve complex measurements, descrip-
tions or equipment.
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There are several respiratory distress instruments from high-income countries (HIC), with
many being developed specifically for single pathologies such as bronchiolitis [9, 15–33]. Sev-
eral models have been developed in resource-limited settings, to assess for primary outcomes
of mortality or antibiotic-treatment failure in children with severe bacterial pneumonia,
namely; The Mamtani score from India, modified Respiratory Index of Severity in Children
(RISC) from Kenya, RISC-Malawi and the original RISC Score from South Africa [15, 34–38].
However, the income and health provisions in these countries are broad, varying between low-
income (LIC) Malawi, and upper-middle income (UMIC) South Africa.
The Liverpool Bronchiolitis Severity Score (LIBSS) and the Respiratory Syncytial Virus Net-
work Scale (ReSViNET), are both bronchiolitis specific scores. LIBSS and ReSViNET have
both previously been assessed for apparent validity (to develop the model) and internal validity
in infants in developed countries with bronchiolitis symptoms [25, 28].
Objectives
This study sought to field-test the use of two scoring instruments (LIBSS and ReSViNET),
assessing the severity of respiratory distress in a population of Rwandan infants (1–12 months)
presenting to urban, tertiary, pediatric hospitals. Specifically, we assessed the usability, inter-
rater reliability and internal consistency of the two instruments. The secondary aim was the
description of the severity of respiratory distress in these infants and the treatments used.
Reasoning for choice of LIBSS and ReSViNET scores
Both the LIBSS and ReSViNET instruments share five parameters and employ clinical parame-
ters assessed by HCPs [15]. The parameters of both scores are applicable to all respiratory dis-
eases that can cause respiratory distress in infants in settings such as Rwanda, and can be
undertaken with no equipment (ReSViNET) or with just a saturation monitor (LIBSS). Specifi-
cally we sought to continue the work of the LIBSS and ReSViNET teams to see if these scores
could be used in our setting, without requiring an assessment of HIV, malaria or chronic
nutritional status, which are required for RISC scores.
Materials and methods
Study design
This was a cross-sectional, multi-centre, validation study, which took place from September
2018 to February 2019. Reporting of this study has been verified in accordance with the TRI-
POD checklist for reporting prediction models [39, 40].
Study sites (data source)
The principal investigator (BH) undertook the study to complete his MMed pediatric resi-
dency at the University of Rwanda. The study was therefore conducted at four public univer-
sity, or university affiliated hospitals in Rwanda, namely; Kigali University Teaching hospital
(CHUK), Rwanda Military Hospital (RMH), Butare University Teaching hospital (CHUB)
and Ruhengeri Referral Hospital (RRH). Recruitment was planned but unsuccessful at King
Faisal Hospital (KFH), a collaborative public-private, university, tertiary hospital. CHUK,
KFH and RMH are all located in Kigali city, the capital of Rwanda. CHUB and RRH are in pro-
vincial towns. All hospitals are tertiary referral centres. These sites are all located in urban set-
tings but receive patients from both rural and urban settings. Patients using the national health
insurance system (“mutuelle de sante”) cannot self-refer to tertiary hospitals and are therefore
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referred from Health Centers and District Hospitals. A small number of paying patients will
self-refer.
Study population
Participants were recruited prospectively from children in both outpatient departments and
the pediatric emergency rooms (ER) at the study sites.
Inclusion criteria. infants 1–12 months of age presenting with respiratory distress due to
any respiratory illness and whose parents could give consent [41, 42].
Our case definition of symptoms and signs indicative of respiratory distress were: apnea,
subcostal or intercostal recession, tracheal tug, nasal flaring, head bobbing, grunting, cyanosis,
oxygen desaturation, tachypnea, wheezing, stridor, oxygen requirement, or reduced air-entry
[25, 28].
Exclusion criteria. infants with known chronic lung disease (CLD), or infants who pre-
sented with a non-respiratory cause of respiratory distress (e.g. cardiac disease).
Sampling. recruitment was opportunistic at the study sites, with infants presenting to the
study sites and meeting the case definition of respiratory distress being approached for
recruitment.
Patient recruitment. The resident pediatrician and/or resident on duty identified eligible
infants. Parents were provided with both verbal and written information about the study. If
they agreed to participate in the study, written informed consent was gained and demographic
details collected.
Clinical care of infants
All data-collectors were HCPs and were involved in the clinical care of the participants, and so
were not blind to the infants’ condition, treatment interventions and patient outcomes. If an
infant required stabilization this was done before recruitment and severity scoring. These
interventions were administration of oxygen, antibiotics and fluids.
Data collection tool
Five data collection tools were used (https://doi.org/10.7910/DVN/N4O05G):
1. Unique Patient Identifier Sheet
2. Study-specific questionnaire: Patient demographics guided by the Demographics and
Health Survey (DHS) parameters [41].
3. LIBSS: A validated score for use in children with bronchiolitis between the ages of 0–12
months. LIBSS has two scoring systems 0–3 months score and 3–12 months to take into
account for age-dependent vital signs [28]. The LIBSS includes ten parameters, namely;
General condition; Apnea; Increased work of breathing; Sa02; Respiratory Rate; Appear-
ance; Heart Rate; Feeding; Urine output; Capillary refill time.
4. ReSViNET: a validated clinical severity scale that was developed to assess the severity of ill-
ness in infants with bronchiolitis [25, 43]. ReSViNET includes seven parameters, namely;
Feeding intolerance; Medical intervention; Respiratory difficulty; Respiratory rate; Apnea;
General condition; Fever
5. Study-specific follow-up questionnaire for final outcomes: admission to pediatric ward;
admission to high dependency unit (HDU) or pediatric intensive care unit (PICU); or
PLOS ONE Field testing LIBSS and ReSViNET in Rwanda
PLOS ONE | https://doi.org/10.1371/journal.pone.0258882 November 4, 2021 4 / 18
outpatient treatment. This section of the questionnaire was specifically designed for the
purposes of this study.
Instrument translation
Most HCPs in Rwanda speak Kinyarwanda (local language), English and/or French. However,
English may not be the first language. Therefore, to overcome language-related barriers, LIBSS
and ReSViNET were translated into Kinyarwanda by the principal investigator (PI) and then
back-translated for accuracy by a native-Kinyarwanda speaking pediatric resident. Translation
discrepancies were reviewed with a third native-Kinyarwanda speaking pediatric resident for
consensus. Within the scoring instruments, the Kinyarwanda translation was presented along-
side the original English.
Instrument availability. The Translated LIBSS and ReSViNET, used in this study, are
available online (https://doi.org/10.7910/DVN/N4O05G). The original ReSVinet was pub-
lished in PLoS and is therefore available under Creative Commons licence CC BY [25] and the
original LIBSS is available under a CC BY attribution [28].
Data-collection
One pediatric resident and one nurse independently assessed each infant using LIBSS and
ReSViNET. The resident and nurse were instructed to not share their LIBSS/ReSViNET find-
ings with each other. Infants were recruited and scored within an hour of presentation to
hospital.
Training data-collectors/assessors
Prior to undertaking assessments, HCPs were given three hours of training on two consecutive
days on how to use the two scores and questionnaires.
Sample size
Data was collected on paper forms, entered into Microsoft Excel and analyzed using SPSS ver-
sion 24. The ’rule of thumb’ to determine the sample size for a clinical field-test is 10–15 times
the number of parameters in a test [44]. This gave a minimum sample size of 100 for LIBSS (10
parameters) and 70 for ReSViNET (7 parameters).
Outcomes, data management and statistical methods
Severity of disease. As there is no “gold standard” for determining the severity of respira-
tory distress, clinical severity was defined by outpatient management (mild), admission (mod-
erate) and severe (HDU/PICI admission). We determined the severity of illness using the
LIBSS and ReSViNET pre-defined cut-points of Mild (0–10); Moderate (11–20); Severe (>21)
for LIBSS [28] and 0–6 for mild affection, 7–13 for moderate distress, and 14–20 using ReSVi-
NET [25, 43].
Validity. Criterion and convergent validity were used to assess whether the instrument
measures what it was intended to measure. Criterion validity (predictive) testing was deter-
mined using the area under aROC based on severity scores of nurse-assessed LIBSS and
ReSViNET. aROCs of 0.50–0.70, 0.70–0.90 and >0.90 were pre-defined as indicating low,
moderate and high validity respectively [44]. Construct validity was assessed by examining the
correlation between LIBSS and other measures of the impact of the disease: hospital admission,
length of stay, HDU/PICU admission and mortality. Length of stay was categorised into binary
criteria of long/short dependent on the median length of stay as a cut-off.
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The two scores use 12 different parameters. Five parameters are shared by the two tools,
namely: Apnea; Feeding intolerance; General condition; Increased work of breathing; and respi-
ratory rate. ReSViNET uses two additional parameters (Fever and medical intervention), and
LIBSS employs five unique parameters (Appearance, Capillary refil time, heart rate, oxygen
requirement and urine output). Therefore, convergent validity of LIBSS and ReSViNET scores
was assessed using Pearson’s r correlation coefficient. Coefficients of 0.4–0.59, 0.6–0.79 and
0.8–1.0 indicating moderate, strong and very strong relationships respectively [45].
Reliability testing. Inter-rater reliability (agreement) was evaluated between paired pediat-
ric resident and nurse responses using the Intraclass Correlation Co-efficiency (ICC) with ICC
<0.75 poor to moderate,>0.75 is good,>0.9 is excellent [44, 46]. Internal consistency of the
parameters within each score was measured using Cronbach alpha, whereby Cronbach’s: <0.70
poor,>0.70 good (if<7 items), interpretation is dependent on number of parameters [44].
Ethical considerations and declarations
Financial disclosure. The author(s) sought nor received any specific funding for this
work.
Potential conflict of interest. The authors have declared that no competing interests
exist.
Confidentiality. Unique Individual Patient Identifier codes were used when completing
the questionnaires. Patient-identifiable information was kept in a separate database to protect
confidentiality.
Informed consent. Informed, written consent, was gained from parents or caregivers.
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participants.
Risk to subjects (including safeguards to mitigate these risks). No significant physical,
social, emotional, legal or financial risks were identified.
Ethical approval. The project proposal was reviewed by the Institutional Review Board
(IRB) at the University of Rwanda. Ethical approval was given (Ref: NO237/CMHSIRB/2018).
The proposal was then reviewed and approved by the ethics committees of each enrolling site.




A total of n = 107 eligible infants were recruited (Fig 1): CHUK (n = 47); RRH (n = 46), CHUB
(n = 9) and RMH (n = 5). Data from seven infants could not be used due to data collection
being incomplete or inadequate, and therefore, these cases were removed. Data most com-
monly omitted were the heart rate and respiratory rate.
Data quality
No data points were missing from the final data set.
Demographic characteristics of the participants
Mean age of participants was seven months (201 days, Standard deviation, SD ±114.7), and 63%
were male. Mean weight and median length of hospital stay (LoS) were 6.6kg (SD±2.4) and 4.0
days (min = 0, max = 39) respectively (Table 1). Participants were diagnosed with pneumonia
(n = 51, 51%), bronchiolitis (n = 36, 36%), viral induced wheezing (n = 6, 6%), upper respiratory
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tract infection (n = 1, 1%) and other infectious respiratory illnesses (n = 6, 6%). Survival rate
was 94% (n = 94). Twenty-eight patients required HDU or PICU management, with 7% (n = 7)
requiring outpatient management alone. The most common co-morbidities were: malnutrition
(n = 12, 12%), prematurity (n = 5, 5%) and HIV (n = 2, 2%) (Table 1).
Severity of disease
ReSViNET described fewer infants (n = 16, 16%) as having severe disease compared to
LIBSS (n = 33, 33%) (Table 2). Most patients presented in moderate or severe respiratory
Fig 1. CONSORT diagram.
https://doi.org/10.1371/journal.pone.0258882.g001
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Mean age (days) 201 (SD ±114.73)
Median age (days) 204
Mean weight (kg) 6.6 (SD ± 2.43)
Median weight (kg) 6.0
Social Group (UbedeheU)
High (3 & 4) 47 (47%)












Single, divorced, Widowed 16 (16%)
Maternal age
Young (<25 years) 32 (32%)
Old (�25years) 68 (68%)
Maternal occupation
Unemployed 19 (19%)








Viral induced wheezing 6 (6%)





HIV positive 2 (2%)
Management
Outpatient 7 (7%)
Pediatric ward 65 (65%)
HDU/PICU 28 (28%)
Median length of stay (days) 4.0
(Continued)
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distress with 87% (n = 87) and 84% (n = 84) having moderate/severe disease on LIBSS and
ReSViNET respectively.
Validity
Convergent validity. The Pearson’s correlation between ReSViNET and LIBSS for resi-
dents (R = 0.815) and nurses (R = 0.836) were both very strong (Table 3 and Fig 2) [45].
Criterion validity (predictive). Both LIBSS and ReSViNET performed well for predicting
hospital admission, HDU/PICU admission and mortality (Table 4). However, they performed
only moderately well for predicting prolonged length of stay (Fig 3).
Reliability
Interrater reliability. The inter-rater reliability between residents and nurses was excel-
lent for both LIBSS (ICC = 0.985) and ReSViNET (ICC = 0.980) (Table 3).
Internal reliability (consistency). Internal consistency for both scores was good with
marginally higher internal consistency for data from the ReSViNET score (Cronbach = 0.850
and 0.848 for nurse and resident scoring respectively) (Table 4). Table 4 demonstrates the reli-
ability of each score if each item is deleted from the score, with only the removal of apnea
resulting a modest increased reliability in both scores.
Treatment
Most participants were treated with antibiotics (pneumonia 100%, bronchiolitis 72% and
other infections 39%) and oxygen therapy (93%) (Table 5). In infants with bronchiolitis, non-
standard therapy including adrenaline (47%), salbutamol nebulization (58%) and steroids
(14%). In patients with severe disease, 5% required intubation and mechanical ventilation
while 8% required CPAP (Table 5).
Discussion
This study sought to field-test the use of two scoring instruments (LIBSS and ReSViNET),
assessing the severity of respiratory distress in a population of 100 Rwandan infants (1–12
Table 1. (Continued)
Characteristic




UUbedehe is the Rwandan community based social classification;
E High = secondary or university completed, Low = primary or no formal education.
https://doi.org/10.1371/journal.pone.0258882.t001
Table 2. Severity of distress LIBSS and ReSViNET.
Mild Moderate Severe
LIBSS Residents 14 48 38
Nurses 13 54 33
ReSVinet Residents 16 67 17
Nurses 16 68 16
https://doi.org/10.1371/journal.pone.0258882.t002
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months) consulting urban, tertiary, pediatric hospitals. The predictive validity, reliability
between raters, and the internal consistency of the two instruments was measured and both
instruments performed well.
Severity of disease
The majority of patients had moderate or severe disease. This likely represents the location of
the field testing and the health structure in Rwanda. Children cannot self-present to tertiary
sites and are therefore referred from Health Centers and District Hospitals, where they will
likely have provided the necessary care of infants with mild disease, without referring to the
tertiary hospitals. The pre-established cut-points of ReSViNET identified fewer infants as hav-
ing severe disease.
Treatments used
Though assessing severity is important, this study also highlights the importance of the
implementation of evidence into clinical practice to ensure that evidence-based treat-
ments are employed. Many patients received unnecessary treatments (Table 5). Antibiot-
ics, adrenaline and/or bronchodilators or not warranted in bronchiolitis but were used
frequently in children with this condition and discontinuing the use of these three inter-
ventions as a key priority [47–49]. Not only is the efficacy of these medications not backed
up by the evidence in the literature, they are also costly for the health care system and fam-
ilies. Further work needs to be undertaken into how to reduce the use of these ineffective
treatments. This is not a Rwandan-specific issue, and this problem has also been described
in developed [50].
Table 3. Validity and reliability results.
LIBSS ReSVinet
Validity statistics
Convergent validity (LIBSS versus
ReSViNET)
Pearson’s correlation (resident) R = 0.815 (CI: 0.70–0.93) (p<0.001)
Pearson’s correlation (nurse) R = 0.836 (CI: 0.73–0.95) (p<0.001)
Criterion Validity for Hospital admission aROC (nurse) 0.956 (CI: 0.88–1.0) (p<0.001) 0.973 (CI: 0.94–1.0) (p<0.001)
aROC (resident) 0.955 (CI: 0.87–1.00) (p<0.001) 0.956 (CI: 0.92–0.99) (p<0.001)
Criterion Validity for HDU/PICU aROC (nurse) 0.956 (CI: 0.92–0.99) (p<0.001) 0.880 (CI: 0.80–0.96) (p<0.001)
aROC (resident) 0.951 (CI: 0.91–0.99) (p<0.001) 0.872 (CI: 0.787–0.957) (p<0.001)
Criterion Validity for mortality aROC (nurse) 0.976 (CI: 0.95–1.0) (p<0.001) 0.974 (CI: 0.944–1.0) (p<0.001)
aROC (resident) 0.974 (CI: 0.94–1.0) (p<0.001) 0.980 (CI: 0.954–1.0) (p<0.001)
Criterion Validity for Length of hospital
stay
aROC (nurse) 0.718 (CI: 0.62–0.82) (p<0.001) 0.637 (CI: 0.531–0.747) (p<0.001)
aROC (resident) 0.722 (CI: 0.62–0. 82) (p<0.001) 0.639 (CI: 0.531–0.747) (p<0.001)
Reliability statistics
Inter-rater reliability Intra-class correlation (Nurse to
resident)
0.985 (CI: 0.98–0.99) (SD±16.741)
(p<0.001)
0.980 (CI: 0.97–0.99) (SD±6.899)
(p<0.001)
HDU = High dependency unit; PICU = Pediatric Intensive Care Unit.
Suggested Interpretation of Validity and Reliability statistics.
aROC (area under Receiver Operating Characteristic): 0.50 = no different than random (i.e. useless), 0.50–0.70 low; 0.70–0.90 moderate, >0.90 high [44].
Intra-class correlation (ICC): <0.75 poor to moderate, >0.75 is good, >0.9 is excellent [44, 46].
Pearson R correlation: R = 0–0.19 very weak, R = 0.2–0.39 weak, R = 0.40–0.59 moderate, R = 0.6–0.79 strong and R = 0.8–1 very strong correlation [45].
https://doi.org/10.1371/journal.pone.0258882.t003
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Validity of the scores
Many healthcare facilities in resource-limited settings will not have medical doctors. There-
fore, the nurse-assessed LIBSS and ReSViNET were used for the validity analyses. There is no
“gold-standard” for assessing respiratory disease. When LIBSS and ReSViNET were measured
against each other, there was a strong correlation between the two scores (Pearson’s >0.8).
The scores use 12 parameters, and as they share five of parameters (apnoea, feeding intoler-
ance, general condition and respiratory rate), the strong correlation is perhaps not surprising,
but it is reassuring that they are scoring severity similarly. Both scores performed highly for
Fig 2. Convergent validity. footnote: R = Pearson’s coefficient, ICC = Intra-class correlation.
https://doi.org/10.1371/journal.pone.0258882.g002
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predicting hospital admission, HDU/PICU admission and mortality. HDU/ICU are not infre-
quently needed to optimize respiratory and medical support, especially in sub-Saharan Africa
[2], however, such care may require the transfer of the patient, is expensive and labour-inten-
sive. Identifying the right patients for this level of care is, therefore, important. The case-defini-
tion used in our inclusion criteria overlapped with the scoring systems that were measured.
Therefore, when interpreting the validity of the instruments it is important to consider that
the sample taken were done so using this case-definition and therefore it is feasible that the
tools will perform very differently in unselected children and in primary care levels.
Reliability
Interrater reliability. The inter-rater reliability was good, with lower confidence limits of
0.98 and 0.97 for LIBSS and ReSViNET, whereby scoring >0.9 is “excellent” [44, 46]. In the
UK, field-testing of LIBSS, the lowest confidence interval for ICC was 0.75 [28], and the ReSVi-
NET gained lowest ICCs of 0.76 between professionals [25]. It is therefore interesting that the
Rwandan professionals scored considerably higher than both these original settings.
Internal consistency. The consistency was better within the ReSViNET, and this is despite
it having fewer parameters (seven versus ten). It is well known that some items may particu-
larly affect reliability within the data and removing this item could see an improvement in
internal consistency, at the cost of content validity. Our data revealed good internal reliability
and only the removal of the measurement of apnoea would have marginally improved the
internal reliability. As Apnoea is an important aspect of respiratory illness in infants (content
validity) we would not advocate removing it.
Use of LIBSS and ReSViNET in the Rwandan setting
The most common co-morbidities were: malnutrition (12%), prematurity (5%) and HIV (2%)
(Table 2). According to the Rwandan DHS 2015 data, 38% of under-5 children are stunted
where 18% of infants between 6 to 8 months are stunted [51]. RISC requires and assessment of
Table 4. Internal reliability (internal consistency) of LIBSS & ReSViNET.
Parameters LIBSS ReSVinet
NURSE RESIDENTS NURSE RESIDENTS
Overall Scale Cronbach 0.831 0.823 0.850 0.848
Reliability if item deleted from scale
LIBSS only Appearance 0.804 0.799 - -
Central capillary refill time 0.820 0.810 - -
Heart rate 0.826 0.822
Oxygen requirement 0.809 0.796 - -
Urine output 0.804 0.801 - -
Shared parameters Apnea 0.833 0.824 0.870 0.864
Feeding 0.804 0.789 0.810 0.817
General condition 0.810 0.808 0.823 0.812
Increased work of breathing 0.809 0.801 0.811 0.808
Respiratory rate 0.831 0.821 0.812 0.810
ReSVinet only Fever - - 0.844 0.843
Medical intervention - - 0.829 0.825
Suggested Interpretation of Validity and Reliability statistics: Cronbach’s: <0.70 poor, >0.70 good (if <7 items), interpretation is dependent on number of
parameters [44].
https://doi.org/10.1371/journal.pone.0258882.t004
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Fig 3. Criterion validity (aROC) of nurse (green) and resident (blue) performed LIBSS and ReSVinet. footnote:
aROC = area under Receiver Operating Characteristic.
https://doi.org/10.1371/journal.pone.0258882.g003
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nutritional status as these infants are particularly prone to worse outcomes. Therefore, using a
respiratory distress score including HIV and/or nutritional assessment is likely to be beneficial.
However, doing so requires additional skills (nutritional assessment) which can add to the
complexity of the scoring.
Comparison of the population with original tools
The major consideration here is that the original scoring tools were designed for infants from
resource-rich settings and for infants with bronchiolitis alone, with other respiratory illnesses
being assessed. The cut-points for disease severity were therefore determined in a different set-
ting with cohorts of patients very different from ours. These factors may account for the lower
criterion validity for HDU/PICU admission with ReSViNET (aROC 0.880) compared to
LIBSS (0.956).
Use of valid and reliable clinical scores in research
As well as using scores in clinical practice severity scores are also useful for clinical trials, in
order to consistently and reliably assess severity of diseases and the effects of treatments. Both
the scores described here are simple to use, without complex investigations or assessments,
and have the potential to be used in research activities in this setting and age group.
Bias
Our population of outpatient-managed cases was only small (n = 7), probably reflecting the
type of hospitals where assessment was undertaken. Usually tertiary and/or referral hospitals
in Rwanda receive critically ill patients transferred from peripheral hospitals. Due to the scar-
city of hospital beds, priority is given to the most critically ill patients. But self-referred patients
with private financial capacity can consult as outpatients. Therefore our population was biased
to either tertiary, referred patients or private self-referring patients.
Limitations
Limitations of our study include the lack of a gold standard for the evaluation of children with
acute respiratory distress and the lack of a mechanism to have an ongoing follow-up. The
other major limitation was our inability to hire full-time data collector nurses at each study
site. This would have potentially increased recruitment and reduced incomplete datasets that
led to seven cases being excluded. We attempted to recruit at a University public-private hospi-
tal, King Faisal Hospital (KFH), a public-private, but only recruited three cases, which was felt
insufficient for inclusion. The reason for poor recruitment was high perceived work load and
reported low admissions of patients with respiratory distress.
Table 5. Treatments used.
Pneumonia (n = 51) Bronchiolitis (n = 36) Other (n = 13)
Antibiotic 51 (100%) 26 (72.2%) 5 (38.5%)
Oxygen therapy 50 (98%) 35 (97.2%) 8 (61.5%)
Salbutamol nebulisation 13 (25.5%) 21 (58.3%) 8 (61.5%)
CPAP (continuous positive airway pressure) 5 (9.8%) 3 (8.3%) 0 (0.0%)
Adrenaline nebulization 4 (7.8%) 17 (47%) 4 (30.8%)
Steroid administration 3 (5.9%) 5 (13.9%) 4 (30.8%)
Intubation and ventilation 1 (2%) 3 (8.3%) 1 (7.7%)
https://doi.org/10.1371/journal.pone.0258882.t005
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The sample size was suitable for field-testing the severity scores and to assess if they are fea-
sible for use. There is however a risk of over-fitting in relation to the prediction measures
(aROCs). The tests we used were created for assessing bronchiolitis rather than all causes of
respiratory illness. They do not assess for HIV, malaria or chronic nutritional status, and these
may have important prognostic implications that require additional resources and HCP skills,
therefore, may impede utilization both in clinical and research applications.
Next steps
In this study, it was not feasible to undertake repeated assessments, and therefore, responsive-
ness was not assessed. Testing responsiveness could have allowed us to monitor progress in
hospital and see if the scores were helpful to identify deterioration or improvement and guide
care. Applying evidence into practice is challenging. These two scores have not been applied in
Rwanda and doing so would require additional work, such as assessing stakeholder attitudes,
along with addressing training needs of those using scores in primary care facilities. When
LIBSS and ReSViNET were measured against each other, there was a strong correlation
between the two scores (Pearson’s >0.8). However, ReSViNET described fewer infants
(n = 16, 16%) as having severe disease compared to LIBSS (n = 33, 33%) (Table 2). Therefore a
larger study to identify appropriate cut-off points, along with responsiveness, would be an
important piece of work to undertake.
Conclusion
The findings of this study are important to the Rwandan health system where facilities have
limited resources, and the decision to admit and escalate care must be carefully considered.
This early data demonstrate that these two scores have the potential to be used in conjunction
with clinical reasoning to identify infants at increased risk of clinical deterioration and allow
timely admission, treatment escalation and therefore support resource allocation in Rwanda.
Supporting information









Pediatric residents and nurses who collected data. Dr Federico Martinón-Torres and Dr Antonio
Justicia of the ReSViNET team and Dr Paul McNamara of LIBSS for reviewing our manuscript.
Author Contributions
Conceptualization: Boniface Hakizimana, Edgar Kalimba, Gemma Saint, Clare van Miert,
Peter Thomas Cartledge.
Data curation: Boniface Hakizimana, Peter Thomas Cartledge.
PLOS ONE Field testing LIBSS and ReSViNET in Rwanda
PLOS ONE | https://doi.org/10.1371/journal.pone.0258882 November 4, 2021 15 / 18
Formal analysis: Boniface Hakizimana, Gemma Saint, Clare van Miert, Peter Thomas
Cartledge.
Investigation: Boniface Hakizimana, Clare van Miert.
Methodology: Boniface Hakizimana, Edgar Kalimba, Augustin Ndatinya, Gemma Saint, Clare
van Miert, Peter Thomas Cartledge.
Project administration: Boniface Hakizimana.
Supervision: Edgar Kalimba, Augustin Ndatinya, Gemma Saint, Clare van Miert, Peter
Thomas Cartledge.
Validation: Boniface Hakizimana.
Writing – original draft: Boniface Hakizimana, Gemma Saint, Peter Thomas Cartledge.
Writing – review & editing: Edgar Kalimba, Augustin Ndatinya, Gemma Saint, Clare van
Miert, Peter Thomas Cartledge.
References
1. Øymar K, Skjerven HO, Mikalsen IB. Acute bronchiolitis in infants, a review. Scand J Trauma Resusc
Emerg Med. BioMed Central; 2014; 22: 23. https://doi.org/10.1186/1757-7241-22-23 PMID: 24694087
2. Rudan I, Boschi-pinto C, Biloglav Z, Campbell H. Epidemiology and etiology of childhood pneumonia.
Bull World Health Organ. 2008; 86: 408–415. https://doi.org/10.2471/blt.07.048769 PMID: 18545744
3. Brown J, Machen H, Kawaza K, Mwanza Z, Iniguez S, Lang H, et al. A High-Value, Low-Cost Bubble
Continuous Positive Airway Pressure System for Low-Resource Settings: Technical Assessment and
Initial Case Reports. PLoS One. 2013; 8: 6–11. https://doi.org/10.1371/journal.pone.0053622 PMID:
23372661
4. Singh V. The burden of pneumonia in children: An Asian perspective. Paediatr Respir Rev. 2005; 6: 88–
93. https://doi.org/10.1016/j.prrv.2005.03.002 PMID: 15911453
5. WHO;UNICEF. Pneumonia: The forgotten killer of children [Internet]. 2006. https://apps.who.int/iris/
bitstream/handle/10665/43640/9280640489_eng.pdf?sequence=1&isAllowed=y
6. Gowraiah V, Awasthi S, Kapoor R, Sahana D, Venkatesh P, Gangadhar B, et al. Can we distinguish
pneumonia from wheezy diseases in tachypnoeic children under low-resource conditions? A prospec-
tive observational study in four Indian hospitals. Arch Dis Child Educ Pract Ed. 2014; 99: 899–906.
https://doi.org/10.1136/archdischild-2013-305740 PMID: 24925892
7. Donoghue AJ, Berg RA, Osmond MH, Wells G, Nesbitt L. Out-of-Hospital Pediatric Cardiac Arrest: An
Epidemiologic Review and Assessment of Current Knowledge. Ann Emerg Med. 2005; 46: 512–522.
https://doi.org/10.1016/j.annemergmed.2005.05.028 PMID: 16308066
8. Collins GS, Moons KGM. Comparing risk prediction models Should be routine when deriving a new
model for the same purpose. 2012; 3186: 1–2. https://doi.org/10.1136/bmj.e3186 PMID: 22628131
9. Duarte-Dorado DM, Madero-Orostegui DS, Rodriguez-Martinez CE, Nino G. Validation of a scale to
assess the severity of bronchiolitis in a population of hospitalized infants. J Asthma. 2013; 50: 1056–61.
https://doi.org/10.3109/02770903.2013.834504 PMID: 24000783
10. Downing SM. Validity: On the meaningful interpretation of assessment data. Medical Education.
2003. pp. 830–837. https://doi.org/10.1046/j.1365-2923.2003.01594.x PMID: 14506816
11. Sullivan GM. A Primer on the Validity of Assessment Instruments. J Grad Med Educ. 2011; 119–120.
https://doi.org/10.4300/JGME-D-11-00075.1 PMID: 22655129
12. Cook DA, Beckman TJ. Current Concepts in Validity and Reliability for Psychometric Instruments: The-
ory and Application. Am J Med. 2006; 119: 166.e7-166.e16. https://doi.org/10.1016/j.amjmed.2005.10.
036 PMID: 16443422
13. Ursachi G, Horodnic IA, Zait A. How reliable are measurement scales? External factors with indirect
influence on reliability estimators. Procedia Econ Financ. Elsevier B.V.; 2015; 20: 679–686. https://doi.
org/10.1016/S2212-5671(15)00123-9
14. Beckman TJ, Mandrekar JN, Engstler GJ, Beckman TJ, Mandrekar JN, Engstler GJ, et al. Determining
Reliability of Clinical Assessment Scores in Real Time Real Time. Teach Learn Med. 2008; 21: 188–
194. https://doi.org/10.1080/10401330903014137 PMID: 20183337
PLOS ONE Field testing LIBSS and ReSViNET in Rwanda
PLOS ONE | https://doi.org/10.1371/journal.pone.0258882 November 4, 2021 16 / 18
15. Hakizimana B, Saint G, Miert C Van, Cartledge P. Can a Respiratory Severity Score Accurately Assess
Respiratory Distress in Children with Bronchiolitis in a Resource-Limited Setting? J Trop Pediatr. 2019;
1–10. https://doi.org/10.1093/tropej/fmy002 PMID: 29415224
16. Marlais M, Evans J, Abrahamson E. Clinical predictors of admission in infants with acute bronchiolitis.
Arch Dis Child. 2011; 96: 648–652. https://doi.org/10.1136/adc.2010.201079 PMID: 21339199
17. Gajdos V, Beydon N, Bommenel L, Pellegrino B, De Pontual L, Bailleux S, et al. Inter-observer agree-
ment between physicians, nurses, and respiratory therapists for respiratory clinical evaluation in bron-
chiolitis. Pediatr Pulmonol. 2009; 44: 754–762. https://doi.org/10.1002/ppul.21016 PMID: 19598273
18. Walsh P, Gonzales A, Satar A, Rothenberg SJ. The interrater reliability of a validated bronchiolitis
severity assessment tool. Pediatr Emerg Care. 2006; 22: 316–20. https://doi.org/10.1097/01.pec.
0000215136.44286.8f PMID: 16714958
19. Walsh P, Rothenberg SJ, O’Doherty S, Hoey H, Healy R. A validated clinical model to predict the need
for admission and length of stay in children with acute bronchiolitis. Eur J Emerg Med. 2004; 11: 265–
272. https://doi.org/10.1097/00063110-200410000-00005 PMID: 15359199
20. Liu LL, Gallaher MM, Davis RL, Rutter CM, Lewis TC, Marcuse EK. Use of a Respiratory Clinical Score
among Different Providers. Pediatr Pulmonol. 2004; 37: 243–248. https://doi.org/10.1002/ppul.10425
PMID: 14966818
21. Chin HJ, Seng QB. Reliability and validity of the respiratory score in the assessment of acute bronchioli-
tis. Malaysian J Med Sci. 2004; 11: 34–40. PMID: 22973125
22. Pavón D, Castro-Rodrı́guez JA, Rubilar L, Girardi G. Relation between pulse oximetry and clinical score
in children with acute wheezing less than 24 months of age. Pediatr Pulmonol. 1999; 27: 423–427.
https://doi.org/10.1002/(sici)1099-0496(199906)27:6<423::aid-ppul10>3.0.co;2-5 PMID: 10380095
23. Alario J. The relationship between oxygen saturation and the clinical assessment of acutely wheezing
infants and children.pdf. Pediatr Emerg Care. 1995; 11: 331–335. https://doi.org/10.1097/00006565-
199512000-00001 PMID: 8751166
24. Caserta MT, Qiu X, Tesini B, Wang L, Murphy A, Corbett A, et al. Development of a Global Respiratory
Severity Score for Respiratory Syncytial Virus Infection in Infants. J Infect Dis. 2017; 215: 6. https://doi.
org/10.1093/infdis/jiw624 PMID: 28011907
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